An academic perspective on the APPEs' educational significance.
Sukkari
Sana R
SR
Sasich
Larry D
LD
Barasain
Mohammed A
MA
D000068:Accreditation; D000085:Acetates / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D003521:Cyclopropanes; D004348:Drug Labeling; D004512:Education, Pharmacy / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D009853:Omeprazole / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D018794:Problem-Based Learning; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D012580:Schools, Pharmacy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013440:Sulfides; D014481:United States
D000085:Acetates; D015283:Citalopram; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D009853:Omeprazole; D054328:Proton Pump Inhibitors; D011804:Quinolines; D017367:Selective Serotonin Reuptake Inhibitors; D013440:Sulfides; C093875:montelukast